ÎÞÓǶÌÊÓƵ

Focus on Tools for the Research, Drug Discovery and Cell Therapy Markets.

The European Patent Office (EPO) upholds ÎÞÓǶÌÊÓƵ's patent for its dual genomic safe harbour technology, opti-oxâ„¢, securing the bro...

ÎÞÓǶÌÊÓƵ's ioSensory Neurons pain research was selected for presentation at SfN’s Neuroscience 2024 press conference.

ÎÞÓǶÌÊÓƵ Wins Honours for Innovation in Synthetic Biology and Exceptional Business Growth.

ÎÞÓǶÌÊÓƵ appoints new Chief Financial Officer, Przemek Obloj

ÎÞÓǶÌÊÓƵ launches panel of 16 neurodegenerative disease models for research and drug discovery in Alzheimer’s and Parkinson’s disea...

ÎÞÓǶÌÊÓƵ launches ioAstrocytes, advancing how scientists can model the human brain.

Bi/ond and ÎÞÓǶÌÊÓƵ collaboration offers a significant advancement for DMD research and drug discovery.